{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Gram Positive Cefoxitin Screen",
        "VITEK 2 AST-GP Cefoxitin Screen",
        "VITEK 2 Gram-Positive Cefoxitin Screen"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K220805",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053097"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTW",
        "LTT"
    ],
    "Summary Letter Date": "March 17, 2022",
    "Summary Letter Received Date": "March 18, 2022",
    "Submission Date": "January 31, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "mecA-mediated oxacillin resistance",
        "Cefoxitin",
        "Oxacillin"
    ],
    "Specimen Type(s)": [
        "Bacterial isolate"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated qualitative antimicrobial susceptibility test",
        "Microdilution minimum inhibitory concentration (MIC)",
        "Optical growth monitoring"
    ],
    "Methodologies": [
        "Automated MIC determination",
        "Discriminant analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-Gram Positive Cefoxitin Screen for prediction of mecA-mediated oxacillin resistance in Staphylococcus spp. using automated MIC determination.",
    "Indications for Use Summary": "Designed to predict mecA-mediated oxacillin resistance in Staphylococcus spp.; intended for use with VITEK 2 and VITEK 2 Compact Systems as a laboratory aid for in vitro susceptibility testing of antimicrobial agents.",
    "fda_folder": "Microbiology"
}